Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Clinical trials with vaccines

Clinical trials with vaccines

Clinical research in humans is currently highly regulated and rigorous from an ethical, logistical and scientific point of view. At all times, the well-being of the participating subject is above the need to achieve some innovative discovery in medicine, even in times of health emergencies.
In many countries, including Panama, there is a research law for drugs, vaccines and devices that, in addition to protecting the person recruited in the trials, supervises the quality and competence of the researchers and their study sites, legislating on the entire experimental process, and protects the legal security of the sponsoring entities (Law 84, May 14, 2009). No study can be carried out in the country without having been registered with the general health department and obtained the approval of the independent bioethics committees.

After the authorization of the project, the participant must go through a meticulous informed consent process that includes knowing extensive information about the potential benefits and risks, data from previous product investigations (in vitro, animal model, previous clinical phase) and the rights or duties in case of accepting your enrollment. The decision is completely voluntary, autonomous, free and devoid of any economic incentive.

The subject can discuss consent with family, friends or professionals before signing. Once inside, the individual must comply with the follow-up visits and with the procedures described in the protocol (vaccinations, sample extractions, records of adverse events, calls or alert messages, etc.). In case of dissatisfaction or inability to adjust to the demands, the person may also choose to withdraw without this causing any kind of affectation.

The proper conduct of a research study is constantly monitored by companies specialized in data monitoring, audited by organizations in charge of quality processes and inspected by regulatory bodies (FDA, EMA, ethics committees), according to the relevance and magnitude of each project. Participants who, by chance, are in the control group, are assigned a comparator vaccine as a benefit, apart from being entitled to medical evaluations and laboratory tests that ensure optimal surveillance of their health condition.

Considerable evidence reveals that people who join clinical trials, even receiving placebo, have advantages over those who do not participate, because they receive frequent personalized attention by a professional team trained and certified in good clinical practice.

At the end of the investigation, if the evaluated product is safe and effective, it is offered free of charge to those who, by random destination, did not have it at the beginning.

Being able to participate in a scientific study is considered a basic human right. Everyone should have that option and in their own country of residence. Any of us, faced with a potentially serious illness, would travel to a place where some new and promising treatment is experienced to improve the prognosis.

Not everyone, unfortunately, has the resources to move to those research sites. Therefore, the bringing of projects to our region should be encouraged. In addition, not all therapy or vaccine behaves the same in Caucasian or Asian populations as in black, mestizo or indigenous populations.

Although the literature indicates that the majority of people who decide to join clinical trials do so for altruistic reasons (to improve the health of others and advance medical knowledge), others hope for a direct benefit or the opportunity to contact professionals trained to discuss health problems for themselves or for their family members.

No academic institution or pharmaceutical corporation risks studying its vaccine in a country that does not provide quality research, ethical rigor and publication in high-impact journals. For the studies on Covid-19, national vaccine researchers have joined in a country project, a consortium or coalition with more than 20 years of experience and trajectory in studies of national and international relevance, both in children and in adults.

Several important projects in the prevention of SARS-CoV-2 infections will soon begin, which will surely provide scientific information on the safety and efficacy of various vaccines, with diverse technological platforms. The advantages of evaluating numerous vaccines worldwide are multiple: greater accessibility, less commercial monopoly, better price and differential value for specific age and risk groups.

Vaccines are, after drinking water, the most cost-effective investment that exists in public health, not only in preventive impact and risk-benefit ratio, but also in the fight against social inequality.

Young people should review history so that they can know the figures of millions of people who died, were paralyzed or suffered serious physical consequences from multiple communicable diseases (polio, measles, rubella, tetanus, diphtheria, tuberculosis, meningitis, pneumonia, whooping cough, diarrhea, hepatitis, chickenpox, etc.) that today have been controlled or eradicated thanks to vaccination. For the few who would like to live without vaccines, this pandemic is the best example of the absence of one; now imagine the world without any.

The author, Xavier Sáez Llorens, is a doctor
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
Vatican hosts first Catholic LGBTQ pilgrimage
Apple Unveils iPhone 17 Series, iPhone Air, Apple Watch 11 and More at 'Awe Dropping' Event
France joins Eurozone’s ‘periphery’ as turmoil deepens, say investors
France Faces New Political Crisis, again, as Prime Minister Bayrou Pushed Out
Nayib Bukele Points Out Belgian Hypocrisy as Brussels Considers Sending Army into the Streets
France, at an Impasse, Heads Toward Another Government Collapse
The Country That Got Too Rich? Public Spending Dominates Norway Election
EU Proposes Phasing Out Russian Oil and Gas by End of 2027 to End Energy Dependence
More Than 150,000 Followers for a Fictional Character: The New Influencers Are AI Creations
EU Prepares for War
Trump Threatens Retaliatory Tariffs After EU Imposes €2.95 Billion Fine on Google
Tesla Board Proposes Unprecedented One-Trillion-Dollar Performance Package for Elon Musk
Gold Could Reach Nearly $5,000 if Fed Independence Is Undermined, Goldman Sachs Warns
Uruguay, Colombia and Paraguay Secure Places at 2026 World Cup
Trump Administration Advances Plans to Rebrand Pentagon as Department of War Instead of the Fake Term Department of Defense
Big Tech Executives Laud Trump at White House Dinner, Unveil Massive U.S. Investments
Tether Expands into Gold Sector with Profit-Driven Diversification
‘Looks Like a Wig’: Online Users Express Concern Over Kate Middleton
Florida’s Vaccine Revolution: DeSantis Declares War on Mandates
Trump’s New War – and the ‘Drug Tyrant’ Fearing Invasion: ‘1,200 Missiles Aimed at Us’
"The Situation Has Never Been This Bad": The Fall of PepsiCo
At the Parade in China: Laser Weapons, 'Eagle Strike,' and a Missile Capable of 'Striking Anywhere in the World'
The Fashion Designer Who Became an Italian Symbol: Giorgio Armani Has Died at 91
Putin Celebrates ‘Unprecedentedly High’ Ties with China as Gazprom Seals Power of Siberia-2 Deal
China Unveils New Weapons in Grand Military Parade as Xi Hosts Putin and Kim
Rapper Cardi B Cleared of Liability in Los Angeles Civil Assault Trial
Google Avoids Break-Up in U.S. Antitrust Case as Stocks Rise
Couple celebrates 80th wedding anniversary at assisted living facility in Lancaster
Information Warfare in the Age of AI: How Language Models Become Targets and Tools
The White House on LinkedIn Has Changed Their Profile Picture to Donald Trump
"Insulted the Prophet Muhammad": Woman Burned Alive by Angry Mob in Niger State, Nigeria
Trump Responds to Death Rumors – Announces 'Missile City'
Druzhba Pipeline Incident Sparks Geopolitical Tensions
Cost of Opposition Leader Péter Magyar's Economic Plan Revealed
Germany in Turmoil: Ukrainian Teenage Girl Pushed to Death by Illegal Iraqi Migrant
United Krack down on human rights: Graham Linehan Arrested at Heathrow Over Three X Posts, Hospitalised, Released on Bail with Posting Ban
Asian and Middle Eastern Investors Avoid US Markets
Ray Dalio Warns of US Shift to Autocracy
Eurozone Inflation Rises to 2.1% in August
Russia and China Sign New Gas Pipeline Deal
Von der Leyen's Plane Hit by Suspected Russian GPS Interference in an Incident Believed to Be Caused by Russia or by Pro-Peace or by Anti-Corruption European Activists
China's Robotics Industry Fuels Export Surge
Suntory Chairman Resigns After Police Probe
Gold Price Hits New All-Time Record
UK Fintechs Explore Buying US Banks
Greece Suspends 5% of Schools as Birth Rate Drops
Apollo to Launch $5 Billion Sports Investment Vehicle
Bolsonaro Trial Nears Close Amid US-Brazil Tension
European Banks Push for Lower Cross-Border Barriers
Poland's Offshore Wind Sector Attracts Investors
×